BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patil AA, Rhee WJ. Exosomes: Biogenesis, Composition, Functions, and Their Role in Pre-metastatic Niche Formation. Biotechnol Bioproc E 2019;24:689-701. [DOI: 10.1007/s12257-019-0170-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Jeong K, Yu YJ, You JY, Rhee WJ, Kim JA. Exosome-mediated microRNA-497 delivery for anti-cancer therapy in a microfluidic 3D lung cancer model. Lab Chip 2020;20:548-57. [PMID: 31942592 DOI: 10.1039/c9lc00958b] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]
2 Kim H, Kang SJ, Rhee WJ. Phenylboronic Acid-conjugated Exosomes for Enhanced Anticancer Therapeutic Effect by Increasing Doxorubicin Loading Efficiency. Biotechnol Bioproc E 2021;26:78-85. [DOI: 10.1007/s12257-020-0107-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rezaie J, Akbari A, Rahbarghazi R. Inhibition of extracellular vesicle biogenesis in tumor cells: A possible way to reduce tumorigenesis. Cell Biochem Funct 2022. [PMID: 35285964 DOI: 10.1002/cbf.3695] [Reference Citation Analysis]
4 Nam GH, Choi Y, Kim GB, Kim S, Kim SA, Kim IS. Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy. Adv Mater 2020;32:e2002440. [PMID: 33015883 DOI: 10.1002/adma.202002440] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 30.5] [Reference Citation Analysis]
5 Vahabi A, Rezaie J, Hassanpour M, Panahi Y, Nemati M, Rasmi Y, Nemati M. Tumor Cells-derived exosomal CircRNAs: Novel cancer drivers, molecular mechanisms, and clinical opportunities. Biochemical Pharmacology 2022;200:115038. [DOI: 10.1016/j.bcp.2022.115038] [Reference Citation Analysis]
6 Sun Z, Yang J, Li H, Wang C, Fletcher C, Li J, Zhan Y, Du L, Wang F, Jiang Y. Progress in the research of nanomaterial-based exosome bioanalysis and exosome-based nanomaterials tumor therapy. Biomaterials 2021;274:120873. [PMID: 33989972 DOI: 10.1016/j.biomaterials.2021.120873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wu L, Wang Y, Xu X, Liu Y, Lin B, Zhang M, Zhang J, Wan S, Yang C, Tan W. Aptamer-Based Detection of Circulating Targets for Precision Medicine. Chem Rev 2021. [PMID: 33667075 DOI: 10.1021/acs.chemrev.0c01140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Maleki M, Golchin A, Javadi S, Khelghati N, Morovat P, Asemi Z, Alemi F, Vaghari-Tabari M, Yousefi B, Majidinia M. Role of exosomal miRNA in chemotherapy resistance of Colorectal cancer: A systematic review. Chem Biol Drug Des 2021. [PMID: 34480511 DOI: 10.1111/cbdd.13947] [Reference Citation Analysis]
9 Kim H, Rhee WJ. Exosome-mediated Let7c-5p Delivery for Breast Cancer Therapeutic Development. Biotechnol Bioproc E 2020;25:513-20. [DOI: 10.1007/s12257-020-0002-0] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Lin B, Lei Y, Wang J, Zhu L, Wu Y, Zhang H, Wu L, Zhang P, Yang C. Microfluidic‐Based Exosome Analysis for Liquid Biopsy. Small Methods 2021;5:2001131. [DOI: 10.1002/smtd.202001131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Hussein NA, Malla S, Pasternak MA, Terrero D, Brown NG, Ashby CR Jr, Assaraf YG, Chen ZS, Tiwari AK. The role of endolysosomal trafficking in anticancer drug resistance. Drug Resist Updat 2021;57:100769. [PMID: 34217999 DOI: 10.1016/j.drup.2021.100769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rizk NI, Abulsoud AI, Kamal MM, Kassem DH, Hamdy NM. Exosomal-long non-coding RNAs journey in colorectal cancer: Evil and goodness faces of key players. Life Sci 2022;292:120325. [PMID: 35031258 DOI: 10.1016/j.lfs.2022.120325] [Reference Citation Analysis]